Coronavirus | Australian Biotech Company News

Home Tags Coronavirus

Biotechnology

Life in the Time of Coronavirus

BioChannel - July 10, 2020

Biotechnology

Newer, More Dominant COVID-19 Variant Is More Infectious in the Lab

BioChannel - July 2, 2020

Biotechnology

Deciphering the Immune Response to Viral Infection

BioChannel - June 8, 2020

Biotechnology

Kicking Up an Immune System Storm: COVID-19 and Hyper-Inflammation

BioChannel - June 1, 2020

Biotechnology

COVID-19 Accurately Diagnosed by AI Model

BioChannel - May 26, 2020

Biotechnology

Promising COVID-19 Antibodies Examined Using Cryo-EM and X-ray Crystallography

BioChannel - May 20, 2020

Biotechnology

Will Covid-19 Change the Face of Vaccine Development?

BioChannel - May 18, 2020

Biotechnology

Critically Ill COVID-19 Patients Recover Following Heart Cell Therapy

BioChannel - May 13, 2020

Biotechnology

EU Pitches Into €7.4B Fund Supporting Covid-19 Treatments & Vaccines

BioChannel - May 7, 2020

Biotechnology

As FDA OKs Emergency Use, Gilead Commits to “Millions More” Remdesivir...

BioChannel - May 4, 2020

12 3...5 Page 1 of 5

Stay connected

Recent posts

Life in the Time of Coronavirus

BioChannel - July 10, 2020

Study pinpoints brain cells that trigger sugar cravings and consumption

BioChannel - July 10, 2020

Life Sciences Fund Launches with €76M to Invest in Nordic Biotech

BioChannel - July 10, 2020

Random article

Life in the Time of Coronavirus

Study pinpoints brain cells that trigger sugar cravings and consumption

Life Sciences Fund Launches with €76M to Invest in Nordic Biotech

VarmX bags €32m in Series B round – European Biotechnology News